資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30159
|
題名: | Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan |
作者: | Cheng, YW;Chiou, HL;Chen, JT;Chou, MC;Lin, TS;Lai, WW;Chen, CY;Tsai, YY;Lee, H |
貢獻者: | 附設醫院眼科部;Chung Shan Med Univ, Lung Canc Res Ctr, Inst Med & Mol Toxicol, Taichung, Taiwan;Chung Shan Med Univ, Inst Med, Taichung, Taiwan;Chugn Shan Med Univ, Sch Med Technol, Taichung, Taiwan;Taichung Vet Gen Hosp, Dept Pathol, Taichung, Taiwan;Changhua Christian Hosp, Dept Surg, Div Cardiothorac, Changhua, Taiwan;Natl Cheng Kung Univ Hosp, Dept Thorac Surg, Tainan 70428, Taiwan;Taichung Vet Gen Hosp, Dept Thorac Surg, Taichung, Taiwan;China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan |
日期: | 2004 |
上傳時間: | 2010-09-24 14:50:18 (UTC+8) |
出版者: | ELSEVIER SCI IRELAND LTD |
摘要: | Glutaryl-CoA dehydrogenase (GCDH) deficiency causes glutaric academia type I (GA-I), an inborn error of metabolism that is characterized clinically by dystonia and dyskinesia and pathologically by neural degeneration of the caudate nucleus and putamen. We report a case of GA-I in a 4-year-old boy. Analysis of blood acylcarnitines by tandem mass spectrometry (MS/MS) revealed a high concentration of glutarylcarnitine in the blood (0.59 muM). Organic acid analysis of urine via gas chromatography mass spectrometry revealed glutaric, acid and 3-hydroxyglutaric acids. In order to search for mutations, the GCDH gene of the patient and his parents were amplified by polymerase chain reaction and subjected to direct sequencing. Two mutations were detected in the patient's GCDH gene. One was located in exon 7 (T713C), which caused a codon 238 leucine to proline substitution; the other was located in intron 10 (IVS10-2 A-to-C), and caused a splicing variation in intron 10 and exon 11. Genetic amniocentesis was requested when the patient's mother became pregnant again, but the fetus did not carry any mutation. Tandem mass spectrometry was successfully used to make the diagnosis of GA-I in this case via identification of genetic mutation. If GA-I can be diagnosed in the early onset or presymptomatic stage, effective therapy would reduce sequelae. |
關聯: | LUNG CANCER 46(2):165-170 |
顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|